Robert Glanzman
Impact in
-
- Multiple Sclerosis Research Studies
-
- Pain Management and Opioid Use
- Pain Management and Treatment
Papers in
-
- Multiple Sclerosis Research Studies 10
-
- Amyotrophic Lateral Sclerosis Research 5
- Parkinson's Disease Mechanisms and Treatments 1
- Neurological Disorders and Treatments 1
- Neuroinflammation and Neurodegeneration Mechanisms 1
- Botulinum Toxin and Related Neurological Disorders 1
- Co-authors
- Miroslav Bačkonja (1 shared paper)Stephen L. Hauser (2 shared papers)David Leppert (3 shared papers)Ludwig Kappos (2 shared papers)David Li (1 shared paper)Paul W O'Connor (1 shared paper)Amit Bar‐Or (1 shared paper)Peter A. Calabresi (1 shared paper)
- Journals
- Neurology (3 papers)Multiple Sclerosis Journal (3 papers)The Lancet (2 papers)Multiple Sclerosis and Related Disorders (2 papers)Journal of the Neurological Sciences (1 paper)
- Partner nations
- United StatesSwitzerlandAustralia
In The Last Decade
Robert Glanzman
18 papers receiving 1.3k citations
Robert Glanzman's Hit Papers
Peers
Comparison fields: 5 of 74
- Pathology and Forensic Medicine 677
- Anesthesiology and Pain Medicine 80
- Neurology 148
- Physiology 181
- Ophthalmology 41
Countries citing papers authored by Robert Glanzman
This map shows the geographic impact of Robert Glanzman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Glanzman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Glanzman more than expected).
Fields of papers citing papers by Robert Glanzman
This network shows the impact of papers produced by Robert Glanzman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Glanzman. The network helps show where Robert Glanzman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Glanzman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial Hit paper breakdown → | 2011 | 609 |
| 2 | 2003 | 342 | |
| 3 | 2007 | 82 | |
| 4 | 2021 | 69 | |
| 5 | 2023 | 43 | |
| 6 | 2021 | 40 | |
| 7 | 1990 | 37 | |
| 8 | 2021 | 36 | |
| 9 | 2023 | 36 | |
| 10 | 2012 | 18 | |
| 11 | 2016 | 14 | |
| 12 | 2025 | 10 | |
| 13 | 2009 | 7 | |
| 14 | 2017 | 4 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2012 | 1 | |
| 18 | 2012 | 1 |
About Robert Glanzman
Robert Glanzman is a scholar working on Pathology and Forensic Medicine, Neurology, Neurology, Pharmacology and Physiology, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (10 papers), Amyotrophic Lateral Sclerosis Research (5 papers), Parkinson's Disease Mechanisms and Treatments (1 paper), Neurological Disorders and Treatments (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Health and Medical Research Impacts (1 paper), Pain Mechanisms and Treatments (1 paper) and Botulinum Toxin and Related Neurological Disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (677 citations), Anesthesiology and Pain Medicine (80 citations), Neurology (148 citations), Physiology (181 citations) and Ophthalmology (41 citations). Robert Glanzman has collaborated with scholars based in United States, Switzerland and Australia. Frequent co-authors include Miroslav Bačkonja, Stephen L. Hauser, David Leppert, Ludwig Kappos, David Li, Paul W O'Connor, Amit Bar‐Or, Peter A. Calabresi, Frederik Barkhof and Robert C. Sergott. Their work appears in journals such as Neurology, Multiple Sclerosis Journal, The Lancet, Multiple Sclerosis and Related Disorders and Journal of the Neurological Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.